PRKAA2 and breast cancer: The increased expression of OCT2 elevated the intracellular accumulation of metformin in an in vivo rat model of the mammary tumor and subsequent 5′ adenosine monophosphate-activated protein kinase (AMPK)-dependent decrease in cell proliferation, tumor volume, and suppression of tumor progression [72,73].